• Je něco špatně v tomto záznamu ?

Czechia: Health System Review

L. Bryndová, L. Šlegerová, J. Votápková, P. Hrobon, N. Shuftan, A. Spranger

. 2023 ; 25 (1) : 1-216. [pub] -

Jazyk angličtina Země Dánsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003894

This analysis of the Czech health system reviews developments in governance, organization, financing and delivery of care, health reforms and health system performance. Czechs have enjoyed a statutory health insurance system with a high level of financial protection, a broad benefits package and universal membership for over 30 years. The central level of the state, mostly represented through the Ministry of Health and its subordinated bodies, takes on the various roles of legislator, steward and even owner of various providers of care, while also making insurance contributions for the sizeable part of the population classified as economically inactive. Health insurance funds are responsible for contracting sufficient care provision for their members. The Czech health system has traditionally derived a majority of its financing from public sources, which stood at 81.5% of current health expenditure in 2019, as the latest available year of reference, with the rest coming from private sources. While health spending in Czechia is below the European Union (EU) average, the densities of acute care beds and primary care physicians are above respective EU averages. Ageing and a lack of qualified staff (for example, nurses in hospitals) are already putting pressure on the Czech health workforce, a bottleneck further exposed by the COVID-19 pandemic. Additionally, Czechia has embarked on a reform process to modernize and centralize specialized tertiary care and psychiatric care. Patients enjoy free choice of primary and specialized outpatient providers, though there are signs that accessibility is limited in some regions and for some specialties. Overall, health outcomes in terms of life expectancy, mortality and survival rates of stroke and cancer have improved in recent years, though these improvements have been slower in Czechia than in other countries. However, life expectancy dropped considerably due to heightened mortality resulting from the COVID-19 pandemic in 2020 and 2021. There remains considerable room for improvement in strengthening disease prevention and health promotion, particularly for dietary habits and health literacy. Various efforts to advance evidence-based interventions in the health system, such as the initiation of health care quality monitoring and health system performance assessment, will assist in further analysing Czechia's health outcomes.

000      
00000naa a2200000 a 4500
001      
bmc23003894
003      
CZ-PrNML
005      
20230425140932.0
007      
ta
008      
230418s2023 dk f 000 0|eng||
009      
AR
035    __
$a (PubMed)36951272
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a dk
100    1_
$a Bryndová, Lucie $u Faculty of Social Sciences, Charles University
245    10
$a Czechia: Health System Review / $c L. Bryndová, L. Šlegerová, J. Votápková, P. Hrobon, N. Shuftan, A. Spranger
520    9_
$a This analysis of the Czech health system reviews developments in governance, organization, financing and delivery of care, health reforms and health system performance. Czechs have enjoyed a statutory health insurance system with a high level of financial protection, a broad benefits package and universal membership for over 30 years. The central level of the state, mostly represented through the Ministry of Health and its subordinated bodies, takes on the various roles of legislator, steward and even owner of various providers of care, while also making insurance contributions for the sizeable part of the population classified as economically inactive. Health insurance funds are responsible for contracting sufficient care provision for their members. The Czech health system has traditionally derived a majority of its financing from public sources, which stood at 81.5% of current health expenditure in 2019, as the latest available year of reference, with the rest coming from private sources. While health spending in Czechia is below the European Union (EU) average, the densities of acute care beds and primary care physicians are above respective EU averages. Ageing and a lack of qualified staff (for example, nurses in hospitals) are already putting pressure on the Czech health workforce, a bottleneck further exposed by the COVID-19 pandemic. Additionally, Czechia has embarked on a reform process to modernize and centralize specialized tertiary care and psychiatric care. Patients enjoy free choice of primary and specialized outpatient providers, though there are signs that accessibility is limited in some regions and for some specialties. Overall, health outcomes in terms of life expectancy, mortality and survival rates of stroke and cancer have improved in recent years, though these improvements have been slower in Czechia than in other countries. However, life expectancy dropped considerably due to heightened mortality resulting from the COVID-19 pandemic in 2020 and 2021. There remains considerable room for improvement in strengthening disease prevention and health promotion, particularly for dietary habits and health literacy. Various efforts to advance evidence-based interventions in the health system, such as the initiation of health care quality monitoring and health system performance assessment, will assist in further analysing Czechia's health outcomes.
650    _2
$a lidé $7 D006801
650    12
$a zdravotní politika $7 D006291
650    _2
$a pandemie $7 D058873
650    12
$a COVID-19 $x epidemiologie $7 D000086382
650    _2
$a výdaje na zdravotnictví $7 D005102
650    _2
$a kvalita zdravotní péče $7 D011787
650    _2
$a zdravotní pojištění $7 D007348
650    _2
$a reforma zdravotní péče $7 D018166
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šlegerová, Lenka $u Institute of Economic Studies, Faculty of Social Sciences, Charles University
700    1_
$a Votápková, Jana $u Institute of Economic Studies, Faculty of Social Sciences, Charles University
700    1_
$a Hrobon, Pavel $u Advance Healthcare Management Institute
700    1_
$a Shuftan, Nathan $u European Observatory on Health Systems and Policies and Department of Health Care Management, Berlin University of Technology
700    1_
$a Spranger, Anne $u European Observatory on Health Systems and Policies and Department of Health Care Management, Berlin University of Technology
773    0_
$w MED00188758 $t Health systems in transition $x 1817-6127 $g Roč. 25, č. 1 (2023), s. 1-216
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36951272 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140929 $b ABA008
999    __
$a ok $b bmc $g 1924507 $s 1190103
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 25 $c 1 $d 1-216 $e - $i 1817-6127 $m Health systems in transition $n Health Syst Transit $x MED00188758
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...